Abbott Laboratories is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Abbott Laboratories performs diagnostics and sells medical devices, medicines, and nutritional products such as Pedialyte. Its products and services help people treat and prevent diseases and chronic conditions. Its treatments help people experiencing pain, movement disorders, diabetes, heart conditions, and more.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Abbott Laboratories is a net-positive Humankind Value company, primarily due to Medical Devices ($94.7 B), Crop Production ($24.6 B), and Healthcare R&D ($23.8 B). Out of every company we have analyzed, Abbott Laboratories is in the top ten for Medical Devices. The value associated with Medical Devices and Healthcare R&D contains our estimation of 2,300,000 additional years lived by people worldwide. The value associated with Crop Production is linked to an estimate of 470,000 equivalent years of life not lost to death or reduction in quality of life. The Humankind Value of this company can improve with reductions in Breastmilk Substitutes (-$100.5 B) and Calorie Conversion (-$19.0 B). Medical Devices, Healthcare R&D, and Breastmilk Substitutes are attached to this company as a result of its direct business activities. Crop Production and Calorie Conversion are largely consequences of the actions of supply chain partners. The direct Humankind Value for this firm, in a vacuum, is negative. But with our supply-chain methodology, a more complete and positive picture of total impact can be seen.